Andrew I. Koven, President & Chief Business Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 9,739 shares at $1.70 ($17K) on 2018-03-19, disclosed to the SEC on 2018-03-21.
Scheduled sale ($17k) by President & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARLZ | SELL | 2017-06-06 | $414K | — | Filing → |
| ARLZ | SELL | 2017-03-22 | $19K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $51K | — | Filing → |